Drug Discovery – SRK Analytics

Accipiter Biosciences Secures Additional $10.5M to Accelerate AI Drug Discovery Programs

Seattle-based biotechnology startup Accipiter Biosciences has secured an additional $10.5 million in seed funding to accelerate its artificial intelligence-driven drug development pipeline. The capital injection allows the company to move…

Prasenjit Bhowmik August 2, 2026

Business Insights

Suven’s High-Stakes Neuroscience Bet Enters Decisive Late-Stage Clinical Trials

Suven Life Sciences, a leading Indian biopharmaceutical innovator, has entered the final stretch of clinical development for its ambitious central nervous system (CNS) pipeline, positioning itself to address some of…

Prasenjit Bhowmik July 20, 2026